Canada Pension Plan Investment Board’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-397,100
Closed -$98K – 1846
2026
Q1
$98K Buy
397,100
+145,200
+58% +$57.8K ﹤0.01% 1650
2025
Q4
$106K Buy
+251,900
New +$134K ﹤0.01% 1802
2014
Q2
– Sell
-1,500
Closed -$27K – 1290
2014
Q1
$27K Sell
1,500
-2,600
-63% -$50.1K ﹤0.01% 1209
2013
Q4
$57K Sell
4,100
-2,000
-33% -$23K ﹤0.01% 1089
2013
Q3
$64K Buy
+6,100
New +$60.6K ﹤0.01% 951

Other funds holding SGMO

Canada Pension Plan Investment Board's SGMO Position: Q2 2026 in Review

Canada Pension Plan Investment Board sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 397,100 shares — an estimated $98K sold.

Canada Pension Plan Investment Board first reported a position in SGMO in Q3 2013 and held it in 5 quarters. The position peaked at $106K in Q4 2025. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

  • Canada Pension Plan Investment Board reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
  • Canada Pension Plan Investment Board sold 397,100 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $98K.
  • Canada Pension Plan Investment Board first reported a position in SANGAMO THERAPEUTICS INC in Q3 2013 and held it in 5 quarters.
  • Canada Pension Plan Investment Board's SANGAMO THERAPEUTICS INC position peaked at $106K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.